Bipolar I Disorder

New National Survey of People Living With Bipolar I Disorder Provides Insights Into Disease-Related Challenges and the Treatment Journey

Summary: 
- Respondents Reported Physical and Psychosocial Impacts of Living with Bipolar I Disorder and Side Effects of Medications Used to Treat the Disease -
- More Than Half of Respondents Reported Trying Five or More Medications During Their Treatment Journey -
- 80% of Respondents Agreed They Wished There Were Medication Options that Relieved Their Bipolar I Disorder Symptoms with Fewer Side Effects -
Press Release
- Respondents Reported Physical and Psychosocial Impacts of Living with Bipolar I Disorder and Side Effects of Medications Used to Treat the Disease -
- More Than Half of Respondents Reported Trying Five or More Medications During Their Treatment Journey -
- 80% of Respondents Agreed They Wished There Were Medication Options that Relieved Their Bipolar I Disorder Symptoms with Fewer Side Effects -

Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month

New Outcomes Research in Patients With Schizophrenia or Bipolar I Disorder to be Presented
Press Release

DUBLINMay 4, 2021 /3BL Media/ -- Alkermes plc (Nasdaq: ALKS) recently announced plans to present clinical data and outcomes research from its psychiatry portfolio at three scientific conferences during Mental Health Awareness Month in May. The meetings, all held virtually, include:

Subscribe to Bipolar I Disorder